|
|
|
|
|
by andy99
338 days ago
|
|
I'm sure they've thought of this but curious how it fared on evaluations for supporting biological threats, ie elevating threat actor capabilities with respect to making biological weapons. I'm personally sceptical that LLMs can currently do this (and it's based on Claude that does test this) but still interesting to see. |
|
> The use of an attenuated B. anthracis strain, low spore concentrations, ineffective dispersal, a clogged spray device, and inactivation of the spores by sunlight are all likely contributing factors to the lack of human cases.
Now you may say, that's bacteria, what about viruses? A similar set of problems would arise, how do you successfully grow virus to high titers? Even vaccine companies struggle to do this with certain viruses. Then the issue of dispersal, infectivity and mortality arise (too quick, it kills the host without spreading and authorities will notice, too slow, same problem: authorities will notice). I haven't even mentioned biological engineering which requires years of technical knowledge and laboratory experience combined with a intimate knowledge of the organism you're working with.
What worries me the most is nature springing a new influenza subtype. Our farming practices, especially in developing countries, is bound to breed a new subtype. It happened in 2009 (H1N1pdm) and it is bound to happen again. We got lucky with H1N1pdm.
1. https://pmc.ncbi.nlm.nih.gov/articles/PMC3322761/ 2. https://en.wikipedia.org/wiki/Tokyo_subway_sarin_attack